Frec Markets Inc’s Journey Medical DERM Stock Holding History

Frec Markets Inc’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$358K	Hold	50,500	–	–	0.03%	649
2026 Q1	$237K	Buy	+50,500	New	+$392K	0.04%	525

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Capital Management

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Frec Markets Inc's DERM Position: Q2 2026 in Review

Frec Markets Inc held its Journey Medical (DERM) position steady in Q2 2026 at 50,500 shares worth $358K. The position accounts for 0.03% of the portfolio, ranked #649.

Frec Markets Inc first reported a position in DERM in Q1 2026 and has held it in 2 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

Frec Markets Inc held 50,500 shares of Journey Medical worth $358K as of Q2 2026.
Frec Markets Inc left its Journey Medical share count unchanged in Q2 2026.
Journey Medical made up 0.03% of Frec Markets Inc's portfolio in Q2 2026, its #649 holding.
Frec Markets Inc first reported a position in Journey Medical in Q1 2026 and has held it in 2 quarters since.
71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Frec Markets Inc's 13F filing for Q2 2026, filed 13 Aug 2026.